These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3967403)

  • 41. Once-daily administration of acebutolol in treatment of hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1985 May; 109(5 Pt 2):1175-8. PubMed ID: 2859782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effective treatment of supraventricular arrhythmias with acebutolol.
    Williams DO; Tatelbaum R; Most AS
    Am J Cardiol; 1979 Sep; 44(3):521-5. PubMed ID: 382821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A multicentre study of a once daily dosage of acebutolol in the treatment of hypertension in general practice.
    Baker PG; Goulton J
    J Int Med Res; 1979; 7(3):201-14. PubMed ID: 456733
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acebutolol (400 mg) given as a single daily dose to hypertensive patients previously stabilized on 400 mg acebutolol daily in divided doses: an open multicentre study.
    Ashton WL
    Curr Med Res Opin; 1977-1978; 5(4):347-53. PubMed ID: 630910
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Treatment of essential arterial hypertension with a single daily dose of acebutolol].
    Saettone GP; Cazzani E; Romanò M; Muzio L
    Minerva Med; 1983 Oct; 74(38):2237-40. PubMed ID: 6646473
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addition of acebutolol to diuretics in hypertension.
    Gorkin JU; Elijovich F; Dziedzic SW; Krakoff LR
    Clin Pharmacol Ther; 1981 Dec; 30(6):739-44. PubMed ID: 6118215
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regression of structural vascular changes after chronic treatment in hypertensives.
    Novo S; Abrignani MG; Liquori M; Corda M; Pinto A; Cosentino F; Strano A
    J Hypertens Suppl; 1991 Dec; 9(6):S202-3. PubMed ID: 1818945
    [No Abstract]   [Full Text] [Related]  

  • 48. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerance of nifedipine retard vs acebutolol in patients with essential hypertension treated for 26 weeks.
    Chamiec T; Zaleska T; Kłoś J; Pietrzykowska H; Bednarz B; Ceremuzyński L
    Mater Med Pol; 1989; 21(1):49-52. PubMed ID: 2634218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The antihypertensive action of acebutolol.
    Low LP; Koh TH
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):11-4. PubMed ID: 7344590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance.
    Plouin PF; Degoulet P; Fermé I; Cornette M; Ménard J
    Eur Heart J; 1983 Nov; 4 Suppl G():7-11. PubMed ID: 6363082
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acebutolol in arterial hypertension. Hemodynamic effects and effects on plasma renin].
    Lucsko M; Chaignon M; Guédon J
    Nouv Presse Med; 1975 Jan; 4(1):21-2, 24-5, 26. PubMed ID: 1144020
    [No Abstract]   [Full Text] [Related]  

  • 53. [Hemodynamic effects of intravenous acebutolol in the acute phase of myocardial infarction].
    Metzger JP; Montgermont P; N'Koua JL; Baubion N; Adams C; Meilhac B; Le Pailleur C; Vacheron A
    Ann Cardiol Angeiol (Paris); 1985 Jun; 34(6):377-80. PubMed ID: 4026163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction.
    Silke B; Nelson G; Verma SP; Clarke J; Baliga G; Taylor SH
    Clin Pharmacol Ther; 1985 Sep; 38(3):266-72. PubMed ID: 4028620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acebutolol in hypertension--double-blind trial against placebo.
    Martin MA; Phillips CA; Smith AJ
    Br J Clin Pharmacol; 1978 Oct; 6(4):351-6. PubMed ID: 359018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of light and moderate arterial hypertension with acebutolol].
    Kaloianova A; Nikolov G; Tsolov S; Sotirov I; Tsanov N
    Vutr Boles; 1986; 25(4):54-60. PubMed ID: 3765591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Interrelationship between changes of rate and variability of cardiac rhythm under influence of beta-adrenoblockers].
    Alekseeva IuM; Malkina TA; Sokolov SF
    Kardiologiia; 2007; 47(12):24-34. PubMed ID: 18260975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive effect of diacetolol in essential hypertension.
    Thibonnier M; Flabeau C; Thouvenin M; Roux A; Flouvat B; Pasquier P; Menard J
    Br J Clin Pharmacol; 1982 Apr; 13(4):533-7. PubMed ID: 6121577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A Brazilian multicenter study to evaluate the clinical effectiveness and tolerance of isradipine SRO using ambulatory monitoring of arterial pressure in the treatment of mild and moderate arterial hypertension].
    Magliano MF; Amodeo C; Mion Júnior D; Francischetti E; Lima Júnior E; Nobre F; Chaves H; Ribeiro JM; Spritzer N; Jardim PC
    Arq Bras Cardiol; 1993 Nov; 61(5):311-8. PubMed ID: 8147731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.